【Introduction】
In global medical research and development, the fields of oncology, cardiovascular diseases, diabetes, and neurology have consistently held the leading positions in terms of research funding, industrial investment, and industry hotspots. The intense competition in these fields undoubtedly promotes medical progress. However, kidney diseases and urology, as essential areas for a large number of patients with chronic diseases, have long suffered from insufficient resource allocation. There is a significant shortage of clinical medication and limited resources for clinical training and teaching. These are areas that urgently need in-depth innovation and development. MAXSEAS focuses on 3D printing anatomical and surgical training models for urology and kidney diseases. It addresses the practical pain points in clinical practice and uses medical-technology innovation to fill the gaps in clinical teaching and preoperative planning in urology.


【The silent burden of chronic diseases】

Renal diseases are known as the "silent epidemic". Their onset is insidious, with no typical symptoms in the early stage. Diagnosis often occurs when the disease has progressed to chronic irreversible damage. Chronic kidney disease, recurrent urinary tract infections, kidney stones, benign prostatic hyperplasia, urinary incontinence, bladder dysfunction - all can occur in people of all ages, spanning from young to middle-aged to elderly.

These chronic diseases do not cause immediate death but continuously erode the quality of patients' lives: frequent hospital visits, long-term physical discomfort, mental anxiety and depression, and continuous increase in family medical expenses. Patients urgently need safe, long-lasting, cost-effective, and standardized treatment plans. At the same time, there are many surgical anatomical variations such as kidneys, complex kidney stones, and lower calyx stones. Young physicians have great difficulty in practical learning due to the complexity. There is a lack of practical teaching aids that can fully reproduce the lesion in clinical practice, and there is also a lack of intuitive reference tools for precise preoperative planning.

【The chronic shortage of supply in the urology and nephrology industry is the core problem】

Low commercialization enthusiasm: Some medical enterprises have prioritized the development of popular disease types with quick monetization and high brand visibility. The specialized chronic disease market in the urology field has been marginalized;

Complex clinical management: Many kidney diseases and urological disorders require long-term individualized medication adjustments. The long follow-up period for chronic diseases raises the entry barriers for enterprises;

Weak public awareness of medical visits: Patients often ignore mild symptoms such as frequent urination, pain during urination, and lower back pain, leading to delayed visits and indirectly weakening the market development momentum.

Shortage of specialized supporting products: There is a lack of differentiated and stable supply of specialized drugs for urological kidney diseases in many regions around the world. The popularity of high-precision 3D anatomical models tailored to individual lesions is insufficient.

【Based on the needs of patients】
As the industry is generally concentrating on the popular medical sector, MAXSEAS has been deeply engaged in the field of 3D printing of medical models, regarding filling the gaps in clinical practice as its own development mission. It has implemented product research and development in four major directions:

1. Adhere to medical-grade quality standards

Renal and urinary system surgeries have strict requirements for anatomical fidelity. Whether it is in regular teaching or preoperative rehearsals for difficult cases, the model's anatomical details and lesion locations must be in line with those of the real human body. MAXSEAS relies on the medical 3D printing quality control system and strictly benchmarks against clinical imaging data to ensure the accuracy of model anatomy, meeting the high standards of clinical training and preoperative rehearsals.

2. Meeting the inclusive needs of various medical institutions

Primary hospitals and medical student training institutions lack expensive anatomical specimen resources. MAXSEAS has optimized the production process to control costs while maintaining model accuracy, enabling all levels of hospitals and medical schools to have access to standardized training models for urology and nephrology.

3. Customized development of exclusive models as per requirements

Unlike standardized mass-produced medical devices, urinary calculi and kidney disorders have significant individual differences. Leveraging a flexible customized development model, MAXSEAS can utilize patient CT images to print personalized disease-specific models, serving for preoperative surgical planning of difficult cases.

4. Deeply integrated with clinical iterative products

MAXSEAS has long been in close contact with clinical physicians and teaching institutions in urology and nephrology across the country. It collects pain points in clinical teaching and intraoperative practical operations. Based on clinical feedback, it continuously iterates the model categories and details, ensuring that the product closely aligns with the actual clinical usage scenarios.

【Summary】

When evaluating the medical value of a disease, we should not use the number of patients or market popularity as the criterion. Patients with impaired kidney function, elderly people suffering from prostate problems, women with recurrent urinary tract infections, and families burdened with the cost of dialysis medications - the medical needs of countless real patients are the underlying driving fo  rce for continuous innovation in the field of urinary kidney diseases. The improvement of physicians' diagnostic and treatment skills cannot be separated from the support of high-quality teaching aids.

For MAXSEAS, industry leadership does not lie in squeezing into the crowded and popular fields, but in continuously raising the industry standards for clinical teaching and preoperative planning in urinary kidney diseases through 3D medical models.

In the future medical industry, enterprises that adhere to the well-being of the people and deeply focus on niche and urgently needed fields will eventually be favored. The demand for urinary kidney diseases is highly stable and there is a huge clinical gap. Every product innovation that is implemented can truly improve the lives of thousands of patients.